Knight Capital Group’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Knight Capital Group’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$29K	Buy	+10,235	New	+$28.3K	﹤0.01%	3133

Other funds holding ONCY

AIM

Acuity Investment Management Toronto, Ontario, Canada $70.8M AUM 0.92% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

AII

AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return

AWMDMG

Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return

RFC

Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Sprott Inc Toronto, Ontario, Canada $3.44B AUM 125.26% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

Knight Capital Group's ONCY Position: Q2 2013 in Review

Knight Capital Group opened a new position in ONCOLYTICS BIOTECH INC (ONCY) in Q2 2013: 10,235 shares worth $29K. The stake represents ﹤0.01% of the portfolio and ranks #3133 among its holdings.

38 funds tracked by Wall St. Rank hold ONCY as of Q2 2013.

Knight Capital Group held 10,235 shares of ONCOLYTICS BIOTECH INC worth $29K as of Q2 2013.
ONCOLYTICS BIOTECH INC was a new Knight Capital Group position in Q2 2013.
ONCOLYTICS BIOTECH INC made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3133 holding.
38 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.